Who is the CEO of Braxia Scientific Corp.?

The CEO of Braxia Scientific Corp. is Peter Rizakos.

What industry does Braxia Scientific Corp. belong to?

Braxia Scientific Corp. operates in the Biotechnology industry within the Healthcare sector.

Where is Braxia Scientific Corp. headquartered?

Braxia Scientific Corp. is headquartered at 1430 Hurontario Street, Mississauga, ON, L5G 3H4, CA.

What is the IPO date of Braxia Scientific Corp.?

Braxia Scientific Corp. went public on March 25, 2020.

How many employees does Braxia Scientific Corp. have?

The total number of employees at Braxia Scientific Corp. is disclosed periodically in the company's annual financial reports.

Braxia Scientific Corp.

BRAXF•PNK

Healthcare

Biotechnology

$0.001

$0.00(0.00%)

Braxia Scientific Corp. (BRAXF) Company Profile & Overview

Explore Braxia Scientific Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Braxia Scientific Corp. (BRAXF) Company Profile & Overview

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. It is also involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and developing ketamine and psilocybin derivatives and other psychedelic products from its IP development platform. In addition, the company owns and operates multidisciplinary clinics for the treatment of mental health disorders. Braxia Scientific Corp. is headquartered in Mississauga, Ontario.

SectorHealthcare

IndustryBiotechnology

CEOPeter Rizakos

Contact Information

https://www.braxiascientific.com

416-430-9619

1430 Hurontario Street, Mississauga, ON, L5G 3H4

Company Facts

IPO DateMar 25, 2020

CountryCA

Actively Trading

Frequently Asked Questions

;